Issued Patents All Time
Showing 1–25 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12398204 | Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist | — | 2025-08-26 |
| 12171751 | Methods of treating intraocular pressure with activators of Tie-2 | — | 2024-12-24 |
| 12152023 | Compositions, formulations and methods for treating ocular diseases | Robert Shalwitz, John Michael Janusz, Alexander Smith | 2024-11-26 |
| 12145986 | Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta) | Michael Allen Flynn | 2024-11-19 |
| 12064420 | Tie-2 activators targeting the Schlemm's canal | — | 2024-08-20 |
| 12043664 | Methods for treating vascular leak syndrome and cancer | Robert Shalwitz | 2024-07-23 |
| 11873334 | Method of treating ocular conditions by administering an antibody that activates Tie2 and binds VEGF | — | 2024-01-16 |
| 11814425 | Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof | Rocco Jamie Rotello, Michael Glenn Davis | 2023-11-14 |
| 11666558 | Methods of treating intraocular pressure with activators of Tie-2 | — | 2023-06-06 |
| 11413242 | Formulations of Tie-2 activators and methods of use thereof | — | 2022-08-16 |
| 11253502 | Tie-2 activators targeting the Schlemm's canal | — | 2022-02-22 |
| 11180551 | Humanized monoclonal antibodies that target VE-PTP (HPTP-beta) | Michael Allen Flynn | 2021-11-23 |
| 11136389 | Humanized monoclonal antibodies that target VE-PTP (HPTP-β) | Michael Allen Flynn | 2021-10-05 |
| 10952992 | Methods of treating intraocular pressure with activators of Tie-2 | — | 2021-03-23 |
| 10894824 | Multispecific antibodies that target HPTP-β (VE-PTP) and VEGF | — | 2021-01-19 |
| 10858354 | HPTP-Beta inhibitors | John Michael Janusz, James Copp | 2020-12-08 |
| 10815300 | Methods for treating vascular leak syndrome and cancer | Robert Shalwitz | 2020-10-27 |
| 10604569 | Humanized monoclonal antibodies that target protein tyrosine phosphatase-beta (HPTP-β/VE-PTP) | Michael Allen Flynn | 2020-03-31 |
| 10597452 | Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta) | Michael Allen Flynn | 2020-03-24 |
| 10329357 | Treatment of ocular disease | Robert Shalwitz | 2019-06-25 |
| 10253094 | Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions | Michael Allen Flynn | 2019-04-09 |
| 10220048 | Compositions and methods for treating ocular diseases | Robert Shalwitz | 2019-03-05 |
| 10150811 | Methods for treating vascular leak syndrome and cancer | Robert Shalwitz | 2018-12-11 |
| 9994560 | HPTP-β inhibitors | John Michael Janusz, James Copp | 2018-06-12 |
| 9949956 | Compounds, compositions, and methods for preventing metastasis of cancer cells | Robert Shalwitz | 2018-04-24 |